Francesco Giorgino discusses the advantages of tirzepatide over insulin degludec revealed in the SURPASS-3 findings for people requiring an injectable therapy for type 2 diabetes (6:00).
View more on Medicine Matters diabetes: [ Ссылка ]
![](https://i.ytimg.com/vi/NxdBWO7mrfw/maxresdefault.jpg)
Francesco Giorgino discusses the advantages of tirzepatide over insulin degludec revealed in the SURPASS-3 findings for people requiring an injectable therapy for type 2 diabetes (6:00).
View more on Medicine Matters diabetes: [ Ссылка ]